- Home
- FDUS vs IMTX Comparison
FDUS vs IMTX Comparison
Compare FDUS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDUS
- IMTX
- Stock Information
- Founded
- FDUS 2011
- IMTX N/A
- Country
- FDUS United States
- IMTX Germany
- Employees
- FDUS N/A
- IMTX N/A
- Industry
- FDUS Finance/Investors Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FDUS Finance
- IMTX Health Care
- Exchange
- FDUS Nasdaq
- IMTX Nasdaq
- Market Cap
- FDUS 654.0M
- IMTX 653.9M
- IPO Year
- FDUS 2011
- IMTX N/A
- Fundamental
- Price
- FDUS $21.22
- IMTX $6.00
- Analyst Decision
- FDUS Hold
- IMTX Strong Buy
- Analyst Count
- FDUS 1
- IMTX 4
- Target Price
- FDUS $20.00
- IMTX $14.67
- AVG Volume (30 Days)
- FDUS 199.8K
- IMTX 662.2K
- Earning Date
- FDUS 07-31-2025
- IMTX 08-12-2025
- Dividend Yield
- FDUS 10.68%
- IMTX N/A
- EPS Growth
- FDUS N/A
- IMTX N/A
- EPS
- FDUS 2.33
- IMTX N/A
- Revenue
- FDUS $147,999,000.00
- IMTX $155,801,989.00
- Revenue This Year
- FDUS $4.94
- IMTX N/A
- Revenue Next Year
- FDUS $6.51
- IMTX $1.92
- P/E Ratio
- FDUS $9.09
- IMTX N/A
- Revenue Growth
- FDUS 9.06
- IMTX 93.56
- 52 Week Low
- FDUS $16.70
- IMTX $3.30
- 52 Week High
- FDUS $23.55
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- FDUS 69.16
- IMTX 61.02
- Support Level
- FDUS $20.68
- IMTX $5.50
- Resistance Level
- FDUS $21.07
- IMTX $6.17
- Average True Range (ATR)
- FDUS 0.29
- IMTX 0.28
- MACD
- FDUS 0.10
- IMTX 0.02
- Stochastic Oscillator
- FDUS 99.90
- IMTX 81.38
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.